Merit E. Cudkowicz, Md
Clinical trials sponsored by Merit E. Cudkowicz, Md, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Massive ALS trial tests multiple drugs at once to find a way to slow the deadly disease Results expected Jul 2027 (estimated)
- New ALS drug trial hopes to slow disease progression Results expected Jul 2027 (estimated)
-
Massive ALS trial tests multiple drugs at once to find a way to slow the deadly disease
Disease control OngoingThis study is testing several experimental treatments at the same time to see if they can slow down ALS, a disease that weakens muscles and gets worse over time. About 1,500 adults with early-stage ALS will take part. The goal is to find treatments that help people stay stronger …
Phase 2/3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New ALS drug trial hopes to slow disease progression
Disease control OngoingThis clinical trial is testing an oral drug called NUZ-001 in 160 people with ALS. Participants take the drug or a placebo daily for 36 weeks. The study measures how the disease progresses using a scale of physical function and survival. The goal is to see if NUZ-001 can slow ALS…
Phase 2/3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC